{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:18:19Z","timestamp":1790817499615,"version":"4.1.0"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["JP21K10136"],"award-info":[{"award-number":["JP21K10136"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Skeletal alterations in the head and neck region, such as midfacial hypoplasia, foramen magnum stenosis and spinal canal stenosis, are commonly observed in patients with mucopolysaccharidosis (MPS). However, enzyme replacement therapy (ERT), one of the major treatment approaches for MPS, shows limited efficacy for skeletal conditions. In this study, we analysed the craniofacial morphology of mice with MPS type VII, and investigated the underlying mechanisms promoting jaw deformities in these animals. Furthermore, we investigated the effects of C-type natriuretic peptide (CNP), a potent endochondral ossification promoter, on growth impairment of the craniofacial region in MPS VII mice when administered alone or in combination with ERT. MPS VII mice exhibited midfacial hypoplasia caused by impaired endochondral ossification, and histological analysis revealed increased number of swelling cells in the resting zone of the spheno-occipital synchondrosis (SOS), an important growth centre for craniomaxillofacial skeletogenesis. We crossed MPS VII mice with transgenic mice in which CNP was expressed in the liver under the control of the human serum amyloid-P component promoter, resulting in elevated levels of circulatory CNP. The maxillofacial morphological abnormalities associated with MPS VII were ameliorated by CNP expression, and further prevented by a combination of CNP and ERT. Histological analysis showed that ERT decreased the swelling cell number, and CNP treatment increased the width of the proliferative and hypertrophic zones of the SOS. Furthermore, the foramen magnum and spinal stenoses observed in MPS VII mice were significantly alleviated by CNP and ERT combination. These results demonstrate the therapeutic potential of CNP, which can be used to enhance ERT outcome for MPS VII-associated head and neck abnormalities.<\/jats:p>","DOI":"10.1371\/journal.pone.0277140","type":"journal-article","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T18:41:11Z","timestamp":1668105671000},"page":"e0277140","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Circulatory C-type natriuretic peptide reduces mucopolysaccharidosis-associated craniofacial hypoplasia in vivo"],"prefix":"10.1371","volume":"17","author":[{"given":"Marina","family":"Kashiwagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4408-4846","authenticated-orcid":true,"given":"Kazumasa","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihito","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko Yamamoto","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizuko","family":"Fukuhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Bessho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,11,10]]},"reference":[{"issue":"suppl_5","key":"pone.0277140.ref001","doi-asserted-by":"crossref","first-page":"v4","DOI":"10.1093\/rheumatology\/ker394","article-title":"Overview of the mucopolysaccharidoses","volume":"50","author":"J. Muenzer","year":"2011","journal-title":"Rheumatology"},{"issue":"1\u20132","key":"pone.0277140.ref002","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ymgme.2018.01.003","article-title":"Clinical presentation and diagnosis of mucopolysaccharidoses","volume":"125","author":"M Stapleton","year":"2018","journal-title":"Molecular genetics and metabolism"},{"issue":"1\u20132","key":"pone.0277140.ref003","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ymgme.2013.06.007","article-title":"Newborn screening and diagnosis of mucopolysaccharidoses","volume":"110","author":"S Tomatsu","year":"2013","journal-title":"Molecular genetics and metabolism"},{"issue":"1","key":"pone.0277140.ref004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-6-72","article-title":"Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease","volume":"6","author":"M Scarpa","year":"2011","journal-title":"Orphanet journal of rare diseases"},{"issue":"7","key":"pone.0277140.ref005","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/bjophthalmol-2012-302913","article-title":"Measuring corneal clouding in patients suffering from mucopolysaccharidosis with the Pentacam densitometry programme","volume":"97","author":"H Elflein","year":"2013","journal-title":"British Journal of Ophthalmology"},{"key":"pone.0277140.ref006","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ymgme.2017.09.011","article-title":"Surgical management of neurological manifestations of mucopolysaccharidosis disorders","volume":"122","author":"TD Alden","year":"2017","journal-title":"Molecular genetics and metabolism"},{"issue":"7","key":"pone.0277140.ref007","first-page":"1402","article-title":"Cervical myelopathy secondary to Hunter syndrome in an adult","volume":"16","author":"M Vinchon","year":"1995","journal-title":"American journal of neuroradiology"},{"issue":"suppl_5","key":"pone.0277140.ref008","doi-asserted-by":"crossref","first-page":"v49","DOI":"10.1093\/rheumatology\/ker396","article-title":"Therapy for the mucopolysaccharidoses","volume":"50","author":"V Valayannopoulos","year":"2011","journal-title":"Rheumatology"},{"issue":"4","key":"pone.0277140.ref009","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.jpeds.2009.07.005","article-title":"Guidelines for the management of mucopolysaccharidosis type I","volume":"155","author":"AM Martins","year":"2009","journal-title":"The Journal of pediatrics"},{"issue":"2","key":"pone.0277140.ref010","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ymgme.2013.11.015","article-title":"Early initiation of enzyme replacement therapy for the mucopolysaccharidoses","volume":"111","author":"J. Muenzer","year":"2014","journal-title":"Molecular genetics and metabolism"},{"issue":"2","key":"pone.0277140.ref011","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3390\/ijms21020500","article-title":"Genome editing for mucopolysaccharidoses","volume":"21","author":"E Poletto","year":"2020","journal-title":"International journal of molecular sciences"},{"issue":"1","key":"pone.0277140.ref012","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1210\/endo.130.1.1309330","article-title":"Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide","volume":"130","author":"S Suga","year":"1992","journal-title":"Endocrinology"},{"issue":"1","key":"pone.0277140.ref013","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ajoms.2016.07.007","article-title":"A novel therapeutic strategy for midfacial hypoplasia using the CNP\/GC-B system","volume":"29","author":"K Nakao","year":"2017","journal-title":"Journal of oral and maxillofacial surgery, medicine, and pathology"},{"issue":"11","key":"pone.0277140.ref014","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.1128\/MCB.18.11.6474","article-title":"Intracisternal A-particle element transposition into the murine \u03b2-glucuronidase gene correlates with loss of enzyme activity: a new model for \u03b2-glucuronidase deficiency in the C3H mouse","volume":"18","author":"B Gwynn","year":"1998","journal-title":"Molecular and cellular biology"},{"issue":"6","key":"pone.0277140.ref015","doi-asserted-by":"crossref","first-page":"E1339","DOI":"10.1152\/ajpendo.00272.2009","article-title":"Chronically elevated plasma C-type natriuretic peptide level stimulates skeletal growth in transgenic mice","volume":"297","author":"T Kake","year":"2009","journal-title":"American Journal of Physiology-Endocrinology and Metabolism"},{"issue":"11","key":"pone.0277140.ref016","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1172\/JCI94912","article-title":"Circulating osteocrin stimulates bone growth by limiting C-type natriuretic peptide clearance","volume":"127","author":"Y Kanai","year":"2017","journal-title":"The Journal of clinical investigation"},{"issue":"7","key":"pone.0277140.ref017","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/sj.gt.3300947","article-title":"Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA","volume":"6","author":"F Liu","year":"1999","journal-title":"Gene therapy"},{"issue":"24","key":"pone.0277140.ref018","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1038\/sj.gt.3301923","article-title":"Gene therapy progress and prospects: nonviral vectors","volume":"9","author":"T Niidome","year":"2002","journal-title":"Gene therapy"},{"issue":"2","key":"pone.0277140.ref019","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqaa008","article-title":"C-type natriuretic peptide restores growth impairment under enzyme replacement in mice with mucopolysaccharidosis VII","volume":"161","author":"T Yamashita","year":"2020","journal-title":"Endocrinology"},{"issue":"1","key":"pone.0277140.ref020","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/0022034512466413","article-title":"The effects of C-type natriuretic peptide on craniofacial skeletogenesis","volume":"92","author":"K Nakao","year":"2013","journal-title":"Journal of dental research"},{"issue":"13","key":"pone.0277140.ref021","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1177\/0022034517716437","article-title":"Circulatory CNP rescues craniofacial hypoplasia in achondroplasia","volume":"96","author":"S Yamanaka","year":"2017","journal-title":"Journal of dental research"},{"issue":"2","key":"pone.0277140.ref022","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2319\/020707-59.1","article-title":"Factors regulating endochondral ossification in the spheno-occipital synchondrosis","volume":"78","author":"WY Lei","year":"2008","journal-title":"The Angle Orthodontist"},{"issue":"1","key":"pone.0277140.ref023","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0003-9861(73)80006-2","article-title":"A \u03b2-glucuronidase deficiency mucopolysaccharidosis: studies in cultured fibroblasts","volume":"155","author":"CW Hall","year":"1973","journal-title":"Archives of biochemistry and biophysics"},{"issue":"3","key":"pone.0277140.ref024","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1203\/00006450-200103000-00007","article-title":"A novel model of murine mucopolysaccharidosis type VII due to an intracisternal a particle element transposition into the \u03b2-glucuronidase gene: clinical and pathologic findings","volume":"49","author":"C Vogler","year":"2001","journal-title":"Pediatric research"},{"issue":"2","key":"pone.0277140.ref025","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4103\/0975-1475.119764","article-title":"Evaluation of spheno-occipital synchondrosis: A review of literature and considerations from forensic anthropologic point of view","volume":"5","author":"K Krishan","year":"2013","journal-title":"Journal of forensic dental sciences"},{"issue":"11","key":"pone.0277140.ref026","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1177\/0022034516651823","article-title":"Developmental regulation of the growth plate and cranial synchondrosis","volume":"95","author":"X Wei","year":"2016","journal-title":"Journal of dental research"},{"issue":"1","key":"pone.0277140.ref027","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00381-013-2245-y","article-title":"The foramen magnum in isolated and syndromic brachycephaly","volume":"30","author":"F Di Rocco","year":"2014","journal-title":"Child\u2019s Nervous System"},{"key":"pone.0277140.ref028","first-page":"1","article-title":"Failures of Endochondral Ossification in the Mucopolysaccharidoses","author":"Z Jiang","year":"2020","journal-title":"Current Osteoporosis Reports"},{"issue":"1","key":"pone.0277140.ref029","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ymgme.2004.01.015","article-title":"Neonatal retroviral vector-mediated hepatic gene therapy reduces bone, joint, and cartilage disease in mucopolysaccharidosis VII mice and dogs","volume":"82","author":"RL Mango","year":"2004","journal-title":"Molecular genetics and metabolism"},{"key":"pone.0277140.ref030","unstructured":"Montagna A. Induced pluripotent stem cells (iPSCs) for modelling mucopolysaccharidosis type I (Hurler syndrome)."},{"issue":"5","key":"pone.0277140.ref031","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1203\/01.PDR.0000156510.96253.5A","article-title":"Joint and bone disease in mucopolysaccharidoses VI and VII: identification of new therapeutic targets and biomarkers using animal models","volume":"57","author":"CM Simonaro","year":"2005","journal-title":"Pediatric research"},{"issue":"1","key":"pone.0277140.ref032","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1111\/j.1651-2227.2011.02385.x","article-title":"Enzyme replacement therapy for mucopolysaccharidosis II from 3 months of age: a 3-year follow-up","volume":"101","author":"A Tylki-Szymanska","year":"2012","journal-title":"Acta Paediatrica"},{"issue":"2","key":"pone.0277140.ref033","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10545-012-9522-x","article-title":"Assessment of bone dysplasia by micro-CT and glycosaminoglycan levels in mouse models for mucopolysaccharidosis type I, IIIA, IVA, and VII","volume":"36","author":"DJ Rowan","year":"2013","journal-title":"Journal of inherited metabolic disease"},{"issue":"5","key":"pone.0277140.ref034","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1148\/rg.2016150168","article-title":"Neuroimaging findings in patients with mucopolysaccharidosis: what you really need to know","volume":"36","author":"R Reichert","year":"2016","journal-title":"Radiographics"},{"issue":"9","key":"pone.0277140.ref035","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s00381-018-3834-6","article-title":"Spinal cord issues in adult patients with MPS: Transition of care survey","volume":"34","author":"KA Ghotme","year":"2018","journal-title":"Child\u2019s Nervous System"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0277140","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T18:41:33Z","timestamp":1668105693000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0277140"}},"subtitle":[],"editor":[{"given":"Joshua B.","family":"Gross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,11,10]]},"references-count":35,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0277140","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,10]]}}}